Dr. Birong Liao is currently a Principal Research Scientist at Integrative Biology Core of Lilly Research Laboratories, coordinating and implementing Informatics technology on the area of Biomarker discovery. Previously, He was the group leader of Expression Profiling Informatics in Pfizer - Ann Arbor laboratories. His research interests are in the area of date integration using principles and theories of mathematics / statistics /physics on data from genetics, genomics, proteomics, metabolomics, in combination with literature mining and network analysis to understand the mechanisms of efficacy and toxicity resulting from drug intervention on disease models, with the goal of predicating better drug targets and biomarkers. Most recently, he is applying these technologies in two therapeutic areas, i. e. atherosclerosis / cardiovascular disease and cancer. He frequently presents his research in academics and industry forums.